Trial Details
Not recruitingBasic Information
| Clinical ID | c3152 |
|---|---|
| Identifier | NCT01809275 |
| Trial Title | A Phase 1/2 Randomized, Placebo-Controlled, Double-Blind Study of the Induction of Clinical Response and Remission by QBECO in Subjects With Moderate to Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Crohn's Disease;Inflammatory Bowel Disease |
| Interventions | Drug: QBECO;Drug: Placebo |
Participant Information
| Sponsor | Qu Biologics Inc. |
|---|---|
| City | - |
| Country/Region | Canada |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |